Startseite>>Signaling Pathways>> GPCR/G protein>> Adrenergic Receptor>>Metaproterenol (hemisulfate)

Metaproterenol (hemisulfate) (Synonyms: dl-Metaproterenol, dl-Orciprenaline)

Katalog-Nr.GC44169

Metaproterenol (Hemisulfat) (Orciprenalin-Hemisulfat) ist ein direkt wirkendes Sympathomimetikum und ein Agonist des β2-adrenergen Rezeptors (β2AR) mit einem IC50 von 68 nM.

Products are for research use only. Not for human use. We do not sell to patients.

Metaproterenol (hemisulfate) Chemische Struktur

Cas No.: 5874-97-5

Größe Preis Lagerbestand Menge
25mg
30,00 $
Auf Lager
50mg
54,00 $
Auf Lager
100mg
95,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Metaproterenol is a β2-adrenergic receptor (β2-AR) agonist with bronchodilator actions. It inhibits TGF-α-induced hepatocyte DNA synthesis and proliferation in vitro (IC50 = 15 nM), an effect that is reversed by the β2-AR antagonist butoxamine but not the β1-AR antagonist metoprolol . Metaproterenol dose-dependently relaxes lung strips and increases heart rate and inotropy of right atria and left atria, respectively, isolated from guinea pig (pD2s = 6.4, 7.08, and 6.61, respectively). Formulations containing metaproterenol were previously used as long-acting bronchodilators for the treatment of asthma.

Bewertungen

Review for Metaproterenol (hemisulfate)

Average Rating: 5 ★★★★★ (Based on Reviews and 25 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Metaproterenol (hemisulfate)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.